X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (416) 416
humans (373) 373
oncology (364) 364
melanoma (338) 338
stage-iii melanoma (262) 262
stage-iii (254) 254
immunotherapy (201) 201
cancer (192) 192
metastatic melanoma (180) 180
female (163) 163
ipilimumab (147) 147
male (140) 140
middle aged (134) 134
survival (127) 127
melanoma - pathology (125) 125
metastasis (125) 125
malignant-melanoma (113) 113
aged (112) 112
surgery (111) 111
adult (104) 104
prognosis (102) 102
cutaneous melanoma (94) 94
skin neoplasms - pathology (94) 94
care and treatment (91) 91
neoplasm staging (86) 86
melanoma - therapy (84) 84
immunology (82) 82
adjuvant therapy (80) 80
melanoma - drug therapy (77) 77
chemotherapy (74) 74
dermatology (71) 71
melanoma - immunology (68) 68
open-label (64) 64
nivolumab (59) 59
phase-ii (59) 59
therapy (59) 59
medicine, research & experimental (57) 57
analysis (55) 55
treatment outcome (55) 55
melanoma - secondary (54) 54
skin neoplasms - drug therapy (54) 54
high-risk melanoma (52) 52
medicine & public health (52) 52
melanoma - surgery (52) 52
patients (52) 52
clinical trials (51) 51
animals (50) 50
double-blind (50) 50
research (50) 50
trial (50) 50
biopsy (49) 49
lymphatic metastasis (49) 49
tumor-infiltrating lymphocytes (49) 49
antineoplastic agents - therapeutic use (48) 48
metastases (48) 48
tumors (46) 46
medical research (45) 45
melanoma - mortality (45) 45
survival rate (45) 45
disease-free survival (44) 44
cancer therapies (42) 42
skin neoplasms - therapy (42) 42
aged, 80 and over (40) 40
cooperative-oncology-group (40) 40
health aspects (40) 40
pembrolizumab (39) 39
immunotherapy - methods (38) 38
interferon (38) 38
retrospective studies (38) 38
skin neoplasms - immunology (38) 38
mutation (37) 37
skin cancer (37) 37
antibodies, monoclonal - therapeutic use (36) 36
drug therapy (36) 36
pegylated interferon-alpha-2b (36) 36
risk factors (36) 36
sentinel lymph node biopsy (35) 35
skin neoplasms - surgery (35) 35
hematology, oncology and palliative medicine (34) 34
lymphatic system (34) 34
multicenter (34) 34
biomarkers (33) 33
cancer vaccines - therapeutic use (33) 33
chemotherapy, adjuvant (33) 33
follow-up studies (32) 32
iv melanoma (32) 32
medical prognosis (32) 32
t cells (32) 32
american joint committee (31) 31
antineoplastic combined chemotherapy protocols - therapeutic use (31) 31
pharmacology & pharmacy (31) 31
targeted therapy (31) 31
combined modality therapy (30) 30
dendritic cells (30) 30
medicine, experimental (30) 30
skin neoplasms - mortality (30) 30
stage iii (30) 30
dissection (29) 29
neoplasm metastasis (29) 29
abridged index medicus (28) 28
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 03/2012, Volume 10, Issue 3, pp. 366 - 400
Journal Article
by Akbani, Rehan and Akdemir, Kadir C and Aksoy, B. Arman and Albert, Monique and Ally, Adrian and Amin, Samirkumar B and Arachchi, Harindra and Arora, Arshi and Auman, J. Todd and Ayala, Brenda and Baboud, Julien and Balasundaram, Miruna and Balu, Saianand and Barnabas, Nandita and Bartlett, John and Bartlett, Pam and Bastian, Boris C and Baylin, Stephen B and Behera, Madhusmita and Belyaev, Dmitry and Benz, Christopher and Bernard, Brady and Beroukhim, Rameen and Bir, Natalie and Black, Aaron D and Bodenheimer, Tom and Boice, Lori and Boland, Genevieve M and Bono, Riccardo and Bootwalla, Moiz S and Bosenberg, Marcus and Bowen, Jay and Bowlby, Reanne and Bristow, Christopher A and Brockway-Lunardi, Laura and Brooks, Denise and Brzezinski, Jakub and Bshara, Wiam and Buda, Elizabeth and Burns, William R and Butterfield, Yaron S.N and Button, Michael and Calderone, Tiffany and Cappellini, Giancarlo Antonini and Carter, Candace and Carter, Scott L and Cherney, Lynn and Cherniack, Andrew D and Chevalier, Aaron and Chin, Lynda and Cho, Juok and Cho, Raymond J and Choi, Yoon-La and Chu, Andy and Chudamani, Sudha and Cibulskis, Kristian and Ciriello, Giovanni and Clarke, Amanda and Coons, Stephen and Cope, Leslie and Crain, Daniel and Curley, Erin and Danilova, Ludmila and D’Atri, Stefania and Davidsen, Tanja and Davies, Michael A and Delman, Keith A and Demchok, John A and Deng, Qixia A and Deribe, Yonathan Lissanu and Dhalla, Noreen and Dhir, Rajiv and DiCara, Daniel and Dinikin, Michael and Dubina, Michael and Ebrom, J. Stephen and Egea, Sophie and Eley, Greg and Engel, Jay and Eschbacher, Jennifer M and Fedosenko, Konstantin V and Felau, Ina and Fennell, Timothy and Ferguson, Martin L and Fisher, Sheila and Flaherty, Keith T and Frazer, Scott and Frick, Jessica and Fulidou, Victoria and Gabriel, Stacey B and Gao, Jianjiong and Gardner, Johanna and Garraway, Levi A and Gastier-Foster, Julie M and Gaudioso, Carmelo and Gehlenborg, Nils and Genovese, Giannicola and Gerken, Mark and Gershenwald, Jeffrey E and Getz, Gad and ... and Canc Genome Atlas Network and Cancer Genome Atlas Network
Cell, ISSN 0092-8674, 06/2015, Volume 161, Issue 7, pp. 1681 - 1696
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 04/2016, Volume 14, Issue 4, pp. 450 - 450
This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Melanoma focuses on adjuvant therapy and treatment of in-transit... 
HIGH-RISK MELANOMA | BACILLUS-CALMETTE-GUERIN | STAGE-III MELANOMA | SENTINEL LYMPH-NODE | ONCOLOGY | CUTANEOUS METASTATIC MELANOMA | CARBON-DIOXIDE LASER | HIGH-DOSE INTERFERON-ALPHA-2B | IN-TRANSIT MELANOMA | ISOLATED LIMB PERFUSION | COOPERATIVE-ONCOLOGY-GROUP
Journal Article
REVUE DE MEDECINE INTERNE, ISSN 0248-8663, 03/2018, Volume 40, Issue 3, pp. 178 - 183
Incidence of malignant melanoma has been increasing since the 1980s. For loco-regional stages, surgery is still the best treatment. Melanoma has a high distant... 
RISK-FACTORS | METAANALYSIS | NODE BIOPSY | Targeted therapy | Melanoma | PHASE-III | IMPROVED SURVIVAL | STAGE-III | METASTATIC MELANOMA | MEDICINE, GENERAL & INTERNAL | DABRAFENIB PLUS TRAMETINIB | Immunotherapy | CUTANEOUS MELANOMA | DOUBLE-BLIND
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 2013, Volume 11, Issue 4, pp. 395 - 407
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 04/2019, Volume 17, Issue 4, pp. 367 - 402
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cutaneous melanoma have been significantly revised over the past few years in response... 
HIGH-RISK MELANOMA | DABRAFENIB PLUS TRAMETINIB | RESECTED STAGE-III | ONCOLOGY | RANDOMIZED PHASE-III | LONG-TERM SURVIVAL | HIGH-DOSE INTERFERON-ALPHA-2B | ADVANCED BRAF(V600)-MUTANT MELANOMA | MUTATED METASTATIC MELANOMA | INVESTIGATOR-CHOICE CHEMOTHERAPY | COOPERATIVE-ONCOLOGY-GROUP
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 4/2014, Volume 21, Issue 4, pp. 1075 - 1081
Journal Article
Nature Communications, ISSN 2041-1723, 12/2017, Volume 8, Issue 1, pp. 592 - 13
Journal Article
Journal Article
Nature Medicine, ISSN 1078-8956, 11/2018, Volume 24, Issue 11, pp. 1649 - 1654
Journal Article